CSBR:NASDAQ
Champions Oncology Inc
US$4.64
arrow_downward
-0.85%(-0.040) 1D
ኖቬም 17, 10:50:28 ጥዋት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
US$4.70
High
US$4.70
Low
US$4.60
Mkt. cap
64.58 ሚ
Avg. vol.
7.80 ሺ
Volume
3.66 ሺ
52-wk high
US$8.31
52-wk low
US$4.52
EPS
-US$0.08
Beta
0.47
Shares outstanding
13.92 ሚ
No. of employees
217
Open
US$4.70
High
US$4.70
Low
US$4.60
Mkt. cap
64.58 ሚ
Avg. vol.
7.80 ሺ
Volume
3.66 ሺ
52-wk high
US$8.31
52-wk low
US$4.52
EPS
-US$0.08
Beta
0.47
Shares outstanding
13.92 ሚ
No. of employees
217
News stories
From web sources and news partners
ChartMill
·
ከ1 ሰዓት በፊት
S&P 500 Stocks Gapping Down in Today's Session
TradingView
·
ከ2 ሰዓቶች በፊት
Wells Fargo sets 2027 S&P 500 year-end target at 8,200
qz.com
·
ከ4 ሰዓቶች በፊት
5 Nasdaq-linked stock indexes and how each differs from the S&P 500
Traders Union
·
ከ30 ደቂቃዎች በፊት
S&P 500 trades near AVWAP and key retracement lines, Chris Ciovacco notes
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ኒው ጄርዚ, ዩናይትድ ስቴትስ
SectorHealth Care
Industry-
Websitechampionsoncology.com